COVID-19 history and symptoms: Difference between revisions
Tags: mobile edit mobile web edit |
Tags: mobile edit mobile web edit |
||
Line 33: | Line 33: | ||
==Less Common Symptoms== | ==Less Common Symptoms== | ||
Less common symptoms of [[COVID-19]] include:<ref name="pmid32400371">{{cite journal| author=Haldrup M, Johansen MI, Fjaeldstad AW| title=[Anosmia and ageusia as primary symptoms of COVID-19]. | journal=Ugeskr Laeger | year= 2020 | volume= 182 | issue= 18 | pages= | pmid=32400371 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32400371 }} </ref><ref name="pmid32104915">{{cite journal |vauthors=Li YC, Bai WZ, Hashikawa T |title=The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients |journal=J. Med. Virol. |volume= |issue= |pages= |date=February 2020 |pmid=32104915 |pmc=7228394 |doi=10.1002/jmv.25728 |url=}}</ref><ref name="pmid32456959">{{cite journal| author=Dockery DM, Rowe SG, Murphy MA, Krzystolik MG| title=The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention. | journal=J Emerg Med | year= 2020 | volume= | issue= | pages= | pmid=32456959 | doi=10.1016/j.jemermed.2020.04.060 | pmc=7205711 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32456959 }} </ref><ref name="pmid32319971">{{cite journal| author=Heidari F, Karimi E, Firouzifar M, Khamushian P, Ansari R, Mohammadi Ardehali M | display-authors=etal| title=Anosmia as a prominent symptom of COVID-19 infection. | journal=Rhinology | year= 2020 | volume= 58 | issue= 3 | pages= 302-303 | pmid=32319971 | doi=10.4193/Rhin20.140 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32319971 }} </ref> | Less common [[symptoms]] of [[COVID-19]] include:<ref name="pmid32400371">{{cite journal| author=Haldrup M, Johansen MI, Fjaeldstad AW| title=[Anosmia and ageusia as primary symptoms of COVID-19]. | journal=Ugeskr Laeger | year= 2020 | volume= 182 | issue= 18 | pages= | pmid=32400371 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32400371 }} </ref><ref name="pmid32104915">{{cite journal |vauthors=Li YC, Bai WZ, Hashikawa T |title=The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients |journal=J. Med. Virol. |volume= |issue= |pages= |date=February 2020 |pmid=32104915 |pmc=7228394 |doi=10.1002/jmv.25728 |url=}}</ref><ref name="pmid32456959">{{cite journal| author=Dockery DM, Rowe SG, Murphy MA, Krzystolik MG| title=The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention. | journal=J Emerg Med | year= 2020 | volume= | issue= | pages= | pmid=32456959 | doi=10.1016/j.jemermed.2020.04.060 | pmc=7205711 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32456959 }} </ref><ref name="pmid32319971">{{cite journal| author=Heidari F, Karimi E, Firouzifar M, Khamushian P, Ansari R, Mohammadi Ardehali M | display-authors=etal| title=Anosmia as a prominent symptom of COVID-19 infection. | journal=Rhinology | year= 2020 | volume= 58 | issue= 3 | pages= 302-303 | pmid=32319971 | doi=10.4193/Rhin20.140 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32319971 }} </ref> | ||
*[[Nausea]] | *[[Nausea]] | ||
*[[Vomiting]] | *[[Vomiting]] |
Revision as of 19:49, 29 June 2020
For COVID-19 frequently asked inpatient questions, click here
For COVID-19 frequently asked outpatient questions, click here
COVID-19 Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
COVID-19 history and symptoms On the Web |
American Roentgen Ray Society Images of COVID-19 history and symptoms |
Risk calculators and risk factors for COVID-19 history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2] Syed Hassan A. Kazmi BSc, MD [3]
Overview
History of patients infected with Coronavirus disease 2019 (COVID-19) can include international travel to where COVID-19 is highly prevalent. The most common symptoms that can appear 2 - 14 days after exposure include fever, cough, fatigue, and shortness of breath.
History
- History of patients infected with Coronavirus disease 2019 (COVID-19) can include international travel to where COVID-19 is highly prevalent.
- In the wake of recent developments, and the declaration of COVID-19 to be a pandemic, the above-mentioned condition is actively evolving.
- History should also be focused on the possible exposure to a confirmed COVID-19 patient.
- In the case of a confirmed diagnosis of COVID-19, thorough and extensive history regarding the close contacts and recent exposure to other healthy/diseased individuals should be taken. Such measures can help in tracking down potential asymptomatic patients.
- To read about the clinical prediction rules for the diagnosis of COVID-19, click here.
Common Symptoms
The following symptoms can appear 2 - 14 days after exposure.[1][2][3][4][5][6] Common symptoms of COVID-19 include:
- Fever
- Cough
- Sinus pain
- Sore throat
- Shortness of breath
- Unusual fatigue
- Chest pain
- Chills
- Body aches
- Nasal congestion
- Nasal secretion
- Headache
Less Common Symptoms
Less common symptoms of COVID-19 include:[7][6][8][9]
- Nausea
- Vomiting
- Diarrhea
- Diminished or lack of sense of smell
- Conjunctivitis
- Loss of taste sensation
- Skin rash
- Discolouration of fingers and toes
References
- ↑ "COVID-19 Symptoms".
- ↑ Yang, Yongshi; Peng, Fujun; Wang, Runsheng; Guan, Kai; Jiang, Taijiao; Xu, Guogang; Sun, Jinlyu; Chang, Christopher (2020). "The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China". Journal of Autoimmunity: 102434. doi:10.1016/j.jaut.2020.102434. ISSN 0896-8411.
- ↑ Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (February 2020). "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China". JAMA. doi:10.1001/jama.2020.1585. PMID 32031570 Check
|pmid=
value (help). - ↑ Velavan, Thirumalaisamy P.; Meyer, Christian G. (2020). "The COVID‐19 epidemic". Tropical Medicine & International Health. 25 (3): 278–280. doi:10.1111/tmi.13383. ISSN 1360-2276.
- ↑ Krajewska J, Krajewski W, Zub K, Zatoński T (April 2020). "COVID-19 in otolaryngologist practice: a review of current knowledge". Eur Arch Otorhinolaryngol. doi:10.1007/s00405-020-05968-y. PMC 7166003 Check
|pmc=
value (help). PMID 32306118 Check|pmid=
value (help). - ↑ 6.0 6.1 Li YC, Bai WZ, Hashikawa T (February 2020). "The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients". J. Med. Virol. doi:10.1002/jmv.25728. PMC 7228394 Check
|pmc=
value (help). PMID 32104915 Check|pmid=
value (help). - ↑ Haldrup M, Johansen MI, Fjaeldstad AW (2020). "[Anosmia and ageusia as primary symptoms of COVID-19]". Ugeskr Laeger. 182 (18). PMID 32400371 Check
|pmid=
value (help). - ↑ Dockery DM, Rowe SG, Murphy MA, Krzystolik MG (2020). "The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention". J Emerg Med. doi:10.1016/j.jemermed.2020.04.060. PMC 7205711 Check
|pmc=
value (help). PMID 32456959 Check|pmid=
value (help). - ↑ Heidari F, Karimi E, Firouzifar M, Khamushian P, Ansari R, Mohammadi Ardehali M; et al. (2020). "Anosmia as a prominent symptom of COVID-19 infection". Rhinology. 58 (3): 302–303. doi:10.4193/Rhin20.140. PMID 32319971 Check
|pmid=
value (help).